News | November 02, 2009

Ascent Healthcare Cleared to Reprocess Biosense Webster SoundStar ICE Catheter

November 2, 2009 — Ascent Healthcare Solutions said last week it received the industry’s first and only 510(k) clearance from the U.S. Food and Drug Administration to reprocess the Biosense Webster SoundStar 3D Diagnostic Ultrasound Catheter.

With this new clearance, Ascent continues to lead the charge in bringing sustainability to healthcare. Ascent’s clearance represents an immediate savings opportunity of up to 51 percent of the cost of the original device, providing hospitals with a solution for more effectively managing device costs associated with their technology investment. In reprocessing the SoundStar catheter, Ascent also brings a value-add environmental benefit by recycling those devices that cannot be reprocessed.

The SoundStar 3D Ultrasound Catheter is a 90 cm 10 Fr. intra-cardiac echo (ICE) catheter with an acoustic array. The catheter has a location sensor (providing location information to the CARTO EP XP Navigation System) and an ultrasound transducer (acquiring real time ultrasound images) embedded in the tip.

For more information: www.ascenths.com

Related Content

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

News | Artificial Intelligence | February 13, 2020
February 13, 2020 — The U.S.
Videos | RSNA | January 13, 2020
ITN Editor Dave Fornell takes a tour of some of the most innovative new medical imaging technologies displayed on the
EchoGo uses artificial intelligence (AI) to calculate cardiac ultrasound left ventricular ejection fraction (EF), the most frequently used measurement of heart function, left ventricular volumes (LV) and, for the first time for an AI application, automated cardiac strain.

EchoGo uses artificial intelligence (AI) to calculate cardiac ultrasound left ventricular ejection fraction (EF), the most frequently used measurement of heart function, left ventricular volumes (LV) and, for the first time for an AI application, automated cardiac strain.

News | Cardiovascular Ultrasound | November 14, 2019
November 14, 2019 — Ultromics has received 510(k) clearance from the U.S.
ASNC Announces Multisocietal Cardiac Amyloidosis Imaging Consensus
News | Cardiac Imaging | September 09, 2019
September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along
Philips Debuts Cardiac Ultrasound and Enterprise Informatics Offerings at ESC 2019
News | Cardiac Imaging | August 30, 2019
Philips will showcase its latest cardiac care innovations at the European Society of Cardiology (ESC) Congress 2019,...
Terason Partners With DiA Imaging Analysis for Point-of-care Cardiac Ultrasound AI
News | Cardiovascular Ultrasound | August 26, 2019
Ultrasound imaging company Terason has partnered with DiA Imaging Analysis, provider of artificial intelligence (AI)-...
Contrast Use in First Transthoracic Echocardiogram for Heart Failure Reduces Repeat Testing
News | Cardiovascular Ultrasound | August 07, 2019
Heart failure is the fourth most common cause for all admission to U.S. hospitals, and it is the most common reason for...
Digital Health Devices Used at Point of Care May Improve Diagnostic Certainty
News | Cardiovascular Ultrasound | August 05, 2019
A West Virginia-based rural medical outreach event showcased the use of point-of-care technology in an ambulatory...
360 Photos | Ultrasound Imaging | July 11, 2019
This 360 degree photo shows a basic, point-of-care cardiac echocardiogram being performed using a smartphone turned i